BACKGROUND/OBJECTIVE: The Food Insulin Index (FII) is a novel algorithm for ranking foods on the basis of insulin responses in healthy subjects relative to an isoenergetic reference food. Our aim was to compare postprandial glycemic responses in adults with type 1 diabetes who used both carbohydrate counting and the FII algorithm to estimate the insulin dosage for a variety of protein-containing foods. SUBJECTS/METHODS: A total of 11 adults on insulin pump therapy consumed six individual foods (steak, battered fish, poached eggs, low-fat yoghurt, baked beans and peanuts) on two occasions in random order, with the insulin dose determined once by the FII algorithm and once with carbohydrate counting. Postprandial glycemia was measured in capillary blood glucose samples at 15-30 min intervals over 3 h. Researchers and participants were blinded to treatment. RESULTS: Compared with carbohydrate counting, the FII algorithm significantly reduced the mean blood glucose level (5.7 ± 0.2 vs 6.5 ± 0.2 mmol/l, P = 0.003) and the mean change in blood glucose level (−0.7 ± 0.2 vs 0.1 ± 0.2 mmol/l, P = 0.001). Peak blood glucose was reached earlier using the FII algorithm than using carbohydrate counting (34 ± 5 vs 56 ± 7 min, P = 0.007). The risk of hypoglycemia was similar in both treatments (48% vs 33% for FII vs carbohydrate counting, respectively, P = 0.155). CONCLUSIONS: In adults with type 1 diabetes, compared with carbohydrate counting, the novel FII algorithm improved postprandial hyperglycemia after consumption of protein-containing foods.
INTRODUCTION
Type 1 diabetes is an autoimmune disorder resulting in an absolute endogenous insulin deficiency that is characterized by chronic hyperglycemia. Effective management of type 1 diabetes requires exogenous insulin to be closely matched to physiologic demand to maintain optimal blood glucose control.
Carbohydrate counting is considered the foundation of intensive insulin therapy, whereby bolus insulin doses are matched to the carbohydrate content of the meal. 1 Despite significant advancements in insulin technology, optimum postprandial glycemic control remains difficult to achieve. Even patients within target glycated hemoglobin A1c levels continue to experience unanticipated hyperglycemia and hypoglycemia, particularly in response to meals high in protein and/or fat. [2] [3] [4] [5] [6] Given the risk of developing life-threatening acute and chronic diabetic complications, improving the insulin dose algorithm presents a significant clinical issue.
The Food Insulin Index (FII) is a novel algorithm of ranking foods on the basis of the insulin response ('demand') in healthy subjects relative to an isoenergetic reference food. 7 Using food energy as the constant allows all foods to be included, not just those with sufficient carbohydrate content, and thus all dietary components and their metabolic interactions can be considered, allowing a more holistic approach to determining insulin demand. Previous studies in healthy people have demonstrated that the FII algorithm is a more accurate predictor of postprandial insulin responses to composite meals than carbohydrate content. 8 A cross-sectional study found no relationship between the FII and glycemic control in healthy adults, but only fasting biomarkers were considered. 9 In individuals with type 1 diabetes, the FII algorithm was associated with improved postprandial glycemia without an increased risk of hypoglycemia compared with carbohydrate counting. 10 However, whether the FII algorithm is a better predictor of exogenous insulin requirement in the case of high-protein foods with relatively little or no carbohydrate has yet to be investigated. In the present study, our aim was to compare the use of carbohydrate counting versus the FII algorithm for estimating insulin dosage on postprandial glycemia in adults with type 1 diabetes consuming six commonly consumed proteincontaining foods.
SUBJECTS AND METHODS
We used a triple-blinded, randomized, within-subject crossover design to compare traditional carbohydrate counting with the FII for estimating insulin dosage on postprandial glycemia in adults, with type 1 diabetes consuming six different single foods. Fifteen adults with type 1 diabetes using insulin pump therapy were recruited through Sydney Insulin Pump Clinic, a private endocrinology clinic in Sydney, Australia. Eligibility criteria included the following: aged between 18 and 70 years; type 1 diabetes diagnosed for ⩾ 1 year; the use of insulin pump therapy, including proficiency with the use of a bolus dose calculator for at least 3 months; hemoglobin A1c between 6.0 and 8.5% (42-69 mmol/mol); and reliably performing self-monitoring of blood glucose at least four times daily. Exclusion criteria included food allergies, intolerances or eating disorders and the use of other medication that may influence blood glucose. The protocol was approved by the Human Research Ethics Committee of the University of Sydney and registered with the Australian New Zealand Clinical Trials Registry (ACTRN12614000170628). Participants gave written informed consent.
Six foods (steak, battered fish, poached eggs, low-fat yoghurt, baked beans and salted peanuts) were selected for the study. These were chosen to represent a cross-section of common protein-containing foods with at least a twofold difference between their carbohydrate content per serving and estimated food insulin demand (FID). FID is the mathematical product of the FII and the energy content (kJ) per normal serving divided by 1000 (FID = FII × kJ per serving/1000). For the purposes of this study only, the FID was scaled up by a factor of 100/59 (FID of 1000 kJ of reference food (pure glucose)/g of carbohydrate in 1000 kJ of reference food) so that the existing insulin ratio programmed in the insulin pump could be applied to both algorithms. Table 1 shows the composition of the foods tested, including the estimated FID based on the published FII (reference) and energy content per serving.
Each of the six single foods was tested in random order on two occasions, once when the insulin requirement was calculated using carbohydrate counting and once using the estimated FID. Rapid-acting insulin was used in both instances using the participants' own insulin pump. A computer-generated randomization table and sealed envelopes were used so that the order of food and algorithm was randomized, and both researchers and participants were blinded to treatment.
During the 2 weeks before study commencement, subjects were reviewed by the credentialled diabetes educator (CDE) to optimize insulin basal rates and insulin-to-carbohydrate ratios. In the 24 h before each testing session, participants were instructed to refrain from the consumption of alcohol and legumes, and any unusual physical activity. On the day of testing, subjects consumed their usual breakfast and lunch meals before presenting to the clinic between 1700 and 1800 hours. If the BGL was ⩾ 10 mmol/l at 1500 hours, the patient administered a correction bolus (normal wave). If the BGL was ⩾ 10 mmol/l at the beginning of the testing session, a correction bolus was administered and the subject was asked to return on another day.
At the start of each session, participants were provided with the test food and the designated insulin bolus. The insulin dose was administered as a normal wave bolus immediately before the meal by the CDE, who was blinded to the algorithm used to calculate the insulin dose, as well as the test food and subjects BGL during the test session. A dietitian prepared the test food and recorded BGL during the test session but was blinded to the insulin dose administered and the algorithm used. Subjects were blinded to the insulin dose, the algorithm and their BGL during the testing session.
Fingerprick capillary blood samples were collected at 0, 15, 30, 45, 60, 90, 120, 150 and 180 min, and the glucose concentration was determined using a blood glucose monitor (HemoCue, Angelholm, Sweden). If hypoglycemia occurred (defined as glucose level 3.5 mmol/l or less), the test session was stopped, the event was recorded and the patient was treated appropriately.
Statistical analysis
Data were analyzed using the SPSS statistical package version 19 (SPSS Inc., Chicago, IL, USA). If the session was stopped owing to hypoglycemia, the last recorded value was carried forward. A general linear model with preprandial blood glucose level as a covariate was used to analyze the following parameters for the two test algorithms: (1) preprandial blood glucose level, (2) mean absolute blood glucose level over 180 min, (3) change in blood glucose over 180 min, (4) peak blood glucose excursion, (5) time to peak blood glucose excursion, (6) mean amplitude of glycemic excursion, (7) time to return to fasting blood glucose level and (8) number of hypoglycemia episodes (defined as blood glucose level ⩽ 3.5 mmol/l). The number of episodes of hypoglycemia was expressed as a proportion of all test sessions and compared by χ 2 -test. Differences in coefficients were considered statistically significant if P-value was o0.05, and highly significant if P-value was o0.01 (two-tailed). Participant characteristics are presented as mean ± s.d. All other results are presented as mean ± s.e., unless otherwise stated.
RESULTS
Of the 15 adults recruited, 11 (4 men, 7 women) completed all testing sessions. One participant failed to finish the test sessions owing to food 'intolerance', another was not available owing to family commitments, one withdrew following hypoglycemia and one had unstable preprandial blood glucose levels on three consecutive occasions and was excluded from further testing.
The mean age of the 11 subjects who completed the study was 38 years (range: 18-62 years), with a mean BMI of 24.6 ± 2.4 (Table 2). They had been diagnosed with type 1 diabetes for 14.4 years (range: 2-37 years) and had been using insulin pump therapy for 3.6 years (range: 1-12 years). The mean hemoglobin A1c was 6.99 ± 0.72% (53 ± 7 mmol/mol).
By chance, baseline (preprandial) blood glucose levels were lower when carbohydrate counting was to be used (6.3 ± − 0.2 vs 6.9 ± 0.2 mmol/l, P = 0.04 for carbohydrate vs FII, respectively). Hence, all remaining summary glucose statistics (Table 3) were adjusted for differences in preprandial glucose concentration.
Mean blood glucose levels over 180 min were significantly lower using the FII algorithm compared with carbohydrate counting (5.7 ± 0.2 vs 6.5 ± 0.2 mmol/l, respectively, P = 0.003) (Table 3, Figure 1 and Figure 2 ). Mean change in blood glucose level over 3 h was also lower using the FII (−0.7 ± 0.2 vs 0.1 ± 0.2 mmol/l, P = 0.001).
Peak blood glucose was also reached earlier using the FII algorithm than using carbohydrate counting (34 ± 5 vs 56 ± 7 min, Abbreviations: BMI, body mass index; HbA1c, hemoglobin A1c.
Food insulin index for protein foods in T1DM KJ Bell et al P = 0.007). Peak change in blood glucose level from baseline tended to be lower when using the FII algorithm compared with carbohydrate counting, although the difference was not significant (1.3 ± 0.2 vs 1.8 ± 0.3 mmol/l, respectively, P = 0.13). In contrast, the maximum amplitude of the glycemic excursion (mean amplitude of glycemic excursion = the difference between the maximum and minimum observed blood glucose values) was significantly larger using the FII algorithm than carbohydrate counting (4.4 ± 0.2 vs 3.7 ± 0.2 mmol/l, P = 0.02).
Mild hypoglycemia requiring cessation of the session per protocol occurred frequently under both conditions and across all foods (Figure 2 ), but there was no difference between the two algorithms (hypoglycemia occurred in 48% vs 33% of all test sessions for FII vs carbohydrate counting, respectively, P = 0.155).
DISCUSSION
The current study demonstrates that the application of the FII to single, protein-containing foods improves postprandial hyperglycemia in comparison with traditional carbohydrate counting. Over the 3-h monitoring period, the FII algorithm reduced the mean blood glucose level by an average of~12%, and reduced the time to reach peak blood glucose concentration by almost half. However, mean amplitude of glycemic excursion was higher using the FII compared with carbohydrate counting, and both treatments were associated with relatively high rates of mild hypoglycemia. Postprandial hyperglycemia is common in everyday life and is associated with an increased risk of developing cardiovascular disease, nephropathy, retinopathy and neuropathy. Abbreviations: Carb, carbohydrate; FII, Food Insulin Index. Data are presented as mean ± s.e., with the exception of the episodes of hypoglycemia, which is presented as the actual number. N = 11 adult subjects with type 1 diabetes using insulin pump therapy. For this study, we specifically chose protein-containing foods where apparent insulin demand was at least twofold higher according to the FII as compared with carbohydrate counting. Indeed, two of the test foods (steak and eggs) contained little or no carbohydrate. We therefore expected to find more hypoglycemia using the FII. However, hypoglycemia (defined as BGL o3.5 mmol/l) occurred frequently under both conditions and across all foods, with no statistical difference between the two algorithms (48% vs 33% for FII vs carbohydrate counting, respectively, P = 0.155). The observed trend toward increased hypoglycemia with the FII seen in this study warrants further investigation given the risks of hypoglycemia in contributing to oxidative stress and diabetes complications. 12, 13 Potentially, the normal wave bolus does not closely follow the normal postprandial physiologic insulin profile for high-protein and/or fat foods, with excess insulin delivered initially resulting in an increased risk of hypoglycemia. Previous research has highlighted the benefit of dual-wave or square insulin bolus delivery patterns in these instances, as well as for low GI meals, as a portion of the total insulin dose is delivered immediately (often 50-70%) and the remainder is delivered slowly over an extended period of time. [14] [15] [16] [17] Further research to elucidate the optimal bolus insulin pattern for foods of varying FII, as well as macronutrient content, is warranted.
Although carbohydrate counting is currently considered the gold standard in determining mealtime insulin dose, it is essentially focused on treating the symptom of type 1 diabetes (hyperglycemia) rather than the underlying cause-the endogenous insulin insufficiency. As an anabolic hormone, insulin has an important role in the metabolism of all three macronutrients: carbohydrate, protein and fat. In healthy subjects, protein elicits a similar insulin response to the same amount of glucose in many slowly digested carbohydrate foods. 18 Fat and protein also increase hepatic glucose output and acute insulin resistance, 5, [19] [20] [21] which may help explain the increased insulin demand for foods rich in these macronutrients and why hypoglycemia was not seen in every test session. In addition, fat and protein also slow gastric emptying and thereby reduce postprandial glycemia compared with meals containing little protein and/or fat. 22, 23 However, carbohydrate counting entirely ignores the presence of fat and protein in foods because it neither directly contributes to glycemia. Our present findings suggest that the FII, based on actual insulin responses in healthy subjects, may be a more reliable predictor of insulin dose in those with type 1 diabetes consuming protein-containing meals.
The strengths of this study include the randomized, controlled design in which researchers, participants and technicians were blinded to treatment. This reduces the risk of bias and improves the reliability of the findings. This study is also the first to explore the concept of FID (FID = FII × kJ per serving/1000), a formula for translating the relative FII values into units proportional to the food portion size. This is a critical step toward applying the FII algorithm in clinical practice. The FID allows a mealtime insulin dose to be calculated based on the FII of the food (or foods) to be consumed and the actual portion size. For the purposes of this study, the FID was scaled so that the FID value could be imputed into the insulin pump without the need to change the subject's existing individualized carbohydrate:insulin ratio. Changes in blood glucose after consuming protein-containing foods using either carbohydrate counting or the food insulin index.
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The study has limitations. Although subjects were instructed to consume their usual breakfast and lunch meals at the same time on each testing day, these meals were not standardized and therefore there may have been a confounder.
Test sessions where the subject experienced hypoglycemia (BGL o3.5 mmol/l) were terminated immediately so that the hypoglycemia could be treated. In these cases, the last recorded blood glucose level was carried forward. Alternately, we could have chosen to assume a consistent gradient in BGLs over the remainder of the recording period. However, imputing any value for missing data raises doubts about the generalizability of the findings. It could also be argued that 3-h recordings are not sufficiently long enough to detect delayed effects of an insulin dose. The efficacy of the FII algorithm over a longer time period should be the subject of further research. In addition, the study was powered to compare mean blood glucose concentrations, rather than prevalence of hypoglycemia. The lack of difference in hypoglycemia may therefore be due to insufficient power. Further studies with a larger sample size are needed.
Despite these limitations, this study adds to a growing body of evidence supporting the use of the novel FII algorithm as a promising tool for predicting prandial insulin dose in adults with type 1 diabetes.
